• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

依托莫昔尔钠盐促进咪唑酮埃拉斯汀诱导的髓源性抑制细胞铁死亡并增强癌症治疗效果。

Etomoxir Sodium Salt Promotes Imidazole Ketone Erastin-Induced Myeloid-Derived Suppressor Cell Ferroptosis and Enhances Cancer Therapy.

作者信息

Mohamady Farouk Abdalsalam Nada, Liang Zihao, Kashaf Tariq Hafiza, Ibrahim Abdulrahman, Li Rong, Wan Xiaochun, Yan Dehong

机构信息

Guangdong Immune Cell Therapy Engineering and Technology Research Center, Center for Protein and Cell-Based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.

University of Chinese Academy of Sciences, Beijing 100864, China.

出版信息

Biology (Basel). 2024 Nov 19;13(11):949. doi: 10.3390/biology13110949.

DOI:10.3390/biology13110949
PMID:39596904
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11592117/
Abstract

Although ferroptosis inducers trigger ferroptotic tumor cells and immune cells in the tumor microenvironment (TME), imidazole ketone erastin (IKE)'s induction of ferroptosis shows no effect on tumor growth in immunocompetent tumor-bearing mice due to the presence of myeloid-derived suppressor cells (MDSCs). Treatment of the carnitine palmitoyltransferase 1a (CPT1A)-specific inhibitor decreases the immunosuppressive function of MDSCs and enhances ferroptotic inducer-initiated tumor cell ferroptosis. However, whether blocking CPT1A could enhance IKE-induced MDSC ferroptosis and thereby inhibit tumor growth is still unclear. Here, we report that a CPT1A-specific inhibitor, etomoxir sodium salt (Eto), and IKE combined treatment increased MDSC ferroptosis. Interestingly, the combination treatment of Eto and IKE blocked MDSCs' immunosuppressive function and accumulation by downregulating the expression of SLC7A11, GPX4, and ARG1 while promoting T-cell proliferation and infiltration into tumor tissues to enhance cancer therapy. These data provide a rationale for the combination therapy of a specific CPT1A inhibitor, Eto, with IKE in clinical settings.

摘要

尽管铁死亡诱导剂可触发肿瘤微环境(TME)中的铁死亡肿瘤细胞和免疫细胞,但由于髓源性抑制细胞(MDSC)的存在,咪唑酮埃拉斯汀(IKE)诱导的铁死亡对免疫健全的荷瘤小鼠的肿瘤生长没有影响。肉碱棕榈酰转移酶1a(CPT1A)特异性抑制剂的治疗可降低MDSC的免疫抑制功能,并增强铁死亡诱导剂引发的肿瘤细胞铁死亡。然而,阻断CPT1A是否能增强IKE诱导的MDSC铁死亡,从而抑制肿瘤生长仍不清楚。在此,我们报告CPT1A特异性抑制剂依托莫昔钠(Eto)与IKE联合治疗可增加MDSC铁死亡。有趣的是,Eto与IKE的联合治疗通过下调SLC7A11、GPX4和ARG1的表达,阻断了MDSC的免疫抑制功能和积累,同时促进T细胞增殖并浸润到肿瘤组织中,从而增强癌症治疗效果。这些数据为在临床环境中使用特定的CPT1A抑制剂Eto与IKE联合治疗提供了理论依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83cf/11592117/745c47dd3055/biology-13-00949-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83cf/11592117/b6a6750e7ccb/biology-13-00949-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83cf/11592117/57ba6a3b3b2d/biology-13-00949-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83cf/11592117/2028a5f5d19f/biology-13-00949-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83cf/11592117/745c47dd3055/biology-13-00949-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83cf/11592117/b6a6750e7ccb/biology-13-00949-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83cf/11592117/57ba6a3b3b2d/biology-13-00949-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83cf/11592117/2028a5f5d19f/biology-13-00949-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83cf/11592117/745c47dd3055/biology-13-00949-g004.jpg

相似文献

1
Etomoxir Sodium Salt Promotes Imidazole Ketone Erastin-Induced Myeloid-Derived Suppressor Cell Ferroptosis and Enhances Cancer Therapy.依托莫昔尔钠盐促进咪唑酮埃拉斯汀诱导的髓源性抑制细胞铁死亡并增强癌症治疗效果。
Biology (Basel). 2024 Nov 19;13(11):949. doi: 10.3390/biology13110949.
2
Blockade of TIPE2-Mediated Ferroptosis of Myeloid-Derived Suppressor Cells Achieves the Full Potential of Combinatory Ferroptosis and Anti-PD-L1 Cancer Immunotherapy.阻断TIPE2介导的髓源性抑制细胞铁死亡可实现联合铁死亡和抗PD-L1癌症免疫治疗的全部潜力。
Cells. 2025 Jan 13;14(2):108. doi: 10.3390/cells14020108.
3
Dicoumarol sensitizes hepatocellular carcinoma cells to ferroptosis induced by imidazole ketone erastin.双香豆素使肝癌细胞对咪唑酮埃拉斯汀诱导的铁死亡敏感。
Front Immunol. 2025 Feb 11;16:1531874. doi: 10.3389/fimmu.2025.1531874. eCollection 2025.
4
Induction of ferroptosis by photodynamic therapy and enhancement of antitumor effect with ferroptosis inducers.光动力疗法诱导铁死亡及铁死亡诱导剂增强抗肿瘤效应。
J Gastroenterol. 2024 Feb;59(2):81-94. doi: 10.1007/s00535-023-02054-y. Epub 2023 Nov 10.
5
Iberverin Downregulates GPX4 and SLC7A11 to Induce Ferroptotic Cell Death in Hepatocellular Carcinoma Cells.伊博韦林通过下调 GPX4 和 SLC7A11 诱导肝癌细胞发生铁死亡。
Biomolecules. 2024 Nov 5;14(11):1407. doi: 10.3390/biom14111407.
6
Imidazole Ketone Erastin Induces Ferroptosis and Slows Tumor Growth in a Mouse Lymphoma Model.咪唑酮类化合物 Erastin 诱导铁死亡并减缓小鼠淋巴瘤模型中的肿瘤生长。
Cell Chem Biol. 2019 May 16;26(5):623-633.e9. doi: 10.1016/j.chembiol.2019.01.008. Epub 2019 Feb 21.
7
Asah2 Represses the p53-Hmox1 Axis to Protect Myeloid-Derived Suppressor Cells from Ferroptosis.Asah2 通过抑制 p53-Hmox1 轴来保护髓源性抑制细胞免于铁死亡。
J Immunol. 2021 Mar 15;206(6):1395-1404. doi: 10.4049/jimmunol.2000500. Epub 2021 Feb 5.
8
Dehydroascorbic acid sensitizes cancer cells to system x inhibition-induced ferroptosis by promoting lipid droplet peroxidation.去氢抗坏血酸通过促进脂滴过氧化来增强癌细胞对系统 xc 抑制诱导的铁死亡敏感性。
Cell Death Dis. 2023 Sep 27;14(9):637. doi: 10.1038/s41419-023-06153-9.
9
Identification of HPCAL1 as a specific autophagy receptor involved in ferroptosis.鉴定 HPCAL1 为一种特异性自噬受体,参与铁死亡。
Autophagy. 2023 Jan;19(1):54-74. doi: 10.1080/15548627.2022.2059170. Epub 2022 Apr 10.
10
Augmented ERO1α upon mTORC1 activation induces ferroptosis resistance and tumor progression via upregulation of SLC7A11.mTORC1 激活诱导 ERO1α 扩增,通过上调 SLC7A11 诱导铁死亡抵抗和肿瘤进展。
J Exp Clin Cancer Res. 2024 Apr 13;43(1):112. doi: 10.1186/s13046-024-03039-2.

引用本文的文献

1
Blockade of TIPE2-Mediated Ferroptosis of Myeloid-Derived Suppressor Cells Achieves the Full Potential of Combinatory Ferroptosis and Anti-PD-L1 Cancer Immunotherapy.阻断TIPE2介导的髓源性抑制细胞铁死亡可实现联合铁死亡和抗PD-L1癌症免疫治疗的全部潜力。
Cells. 2025 Jan 13;14(2):108. doi: 10.3390/cells14020108.
2
MDSC: a new potential breakthrough in CAR-T therapy for solid tumors.髓源性抑制细胞:嵌合抗原受体T细胞疗法在实体瘤治疗中的一个新的潜在突破点
Cell Commun Signal. 2024 Dec 19;22(1):612. doi: 10.1186/s12964-024-01995-y.